The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Guy Yehiav In the U.S., ...

AI Conductor operates as an orchestration layer across PhaseV’s vertical AI platform.

The clinical trial process is broken for a variety of reasons, ranging from the difficulty of designing trial protocols to the cost of running them. But one critical (and solvable) issue is finding, ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial ...

In today’s globalized pharma environment, technical and supply chain challenges in the clinical trial process create ripple effects felt by stakeholders across regions and functions. This has created ...

START will leverage Trialing’s platform to distribute curated information on ongoing early-phase oncology trials.

Expanding clinical trial access locally reduces logistical and financial barriers, making participation feasible for underserved populations. Addressing myths about clinical trials helps patients ...

Clinical trial agreements (CTAs) form the foundation of any clinical research initiative, establishing the legal and operational framework essential for a study's success. Crafting, reviewing, and ...

Automation consistently comes up to help tackle today’s complexity in clinical trials, but there are different ideas of what it is and where it is useful. We asked several leaders in trial operations, ...

This article was paid for by Pfizer and provided by the Pfizer Multicultural Health Equity Collective in collaboration with UnidosUS. The views expressed are theirs alone. This article has not been ...